PHILADELPHIA, June 10, 2026 /PRNewswire/ -- Following the Philadelphia City Council's vote to pass a bill classifying kratom and hemp-derived products as "intoxicating substances,"...
In the news release, O Positiv Health Releases Its First Prenatal, PREGGO Prenatal + Probiotic, issued 10-Feb-2026 by O Positiv Health over PR Newswire,...
Acquisition expands Nagase America's coatings capabilities with dedicated testing, training, and technical innovation lab in Costa Mesa, CaliforniaITASCA, Ill., June 10, 2026 /PRNewswire/ -- Nagase...
Matthew Williamson Returns to Fashion with Exclusive Free People CapsulePHILADELPHIA, June 10, 2026 /PRNewswire/ -- British designer Matthew Williamson makes his return to fashion...
TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026.
Following a second federal trial, a D.C. jury acquitted Guanghua Jin of lead bank fraud conspiracy. Remaining counts were resolved via a plea agreement.
Recognition for 10-year performance underscores Lear's differentiated, research-driven approach to active managementDALLAS, June 10, 2026 /PRNewswire/ -- Lear Investment Management ("Lear"), a Dallas-based SEC-registered...
RENO, Nev., June 10, 2026 /PRNewswire/ -- Vallige, Inc., a service built to comfort people with dementia and reduce caregiver burden, today announced the...